Is long-term chronic immunosuppression therapy detrimental in hepatitis C virus-positive renal transplant patients?
Rostaing
L
L
Multi-Organ Transplant Unit, Toulouse University Hospital, France.
Izopet
J
J
Cisterne
J M
JM
Arnaud
C
C
Duffaut
M
M
Rumeau
J L
JL
Puel
J
J
Durand
D
D
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000150:complications* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008099:Liver / Q000473:pathology / Q000821:virology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D016572:Cyclosporine; D001379:Azathioprine